Vitamin D deficiency: An increasing concern in peripheral arterial disease

Journal of the American Medical Directors Association

Volumn 11, Issue 5, 2010, Pages 308-311

  Gaddipati, Vamsi C ^a   Kuriacose, Reena ^a   Copeland, Rebecca ^a   Bailey, Beth A ^a   Peiris, Alan N ^a,b  

^a EAST TENNESSEE STATE UNIVERSITY   (United States)

^b James H Quillen VA Medical Center   (United States)

Author keywords

Peripheral vascular disease; Vitamin D deficiency

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERCELLULAR ADHESION MOLECULE 1; LOW DENSITY LIPOPROTEIN CHOLESTEROL; VITAMIN D;

ARTERIAL WALL THICKNESS; ARTERY DISEASE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; HUMAN; HYPERTRIGLYCERIDEMIA; NONHUMAN; REVIEW; RISK FACTOR; VASCULAR DISEASE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

EID: 77953336612     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2010.02.002     Document Type: Review

References (57)

1. Selvin E., Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: Results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 2004, 110:738-743.
2. Stehouwer C.D., Clement D., Davidson C., et al. Peripheral arterial disease: A growing problem for the internist. Eur J Intern Med 2009, 20:132-138.
3. Arain F.A., Cooper L.T. Peripheral arterial disease: Diagnosis and management. Mayo Clin Proc 2008, 83:944-949. quiz 949-950.
4. Flu H., van der Hage J.H., Knippenberg B., Merkus J.W., Hamming J.F., Lardenoye J.W. Treatment for peripheral arterial obstructive disease: An appraisal of the economic outcome of complications. J Vasc Surg 2008, 48:368-376.
5. Golomb B.A., Dang T.T., Criqui M.H. Peripheral arterial disease: Morbidity and mortality implications. Circulation 2006, 114:688-699.
6. Hiatt W.R. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001, 344:1608-1621.
7. Eagle K.A., Rihal C.S., Foster E.D., et al. Long-term survival in patients with coronary artery disease: Importance of peripheral vascular disease. The Coronary Artery Surgery Study (CASS) Investigators. J Am Coll Cardiol 1994, 23:1091-1095.
8. Eastridge D.K. An integrative review of interventions to reduce peripheral arterial disease risk factors in African Americans. J Vasc Nurs 2009, 27:31-45.
9. Nelson K.M., Reiber G., Kohler T., Boyko E.J. Peripheral arterial disease in a multiethnic national sample: The role of conventional risk factors and allostatic load. Ethn Dis 2007, 17:669-675.
10. Gallotta G., Iazzetta N., Milan G., Ruocco A., Napoli C., Postiglione A. Prevalence of peripheral arterial disease in an elderly rural population of southern Italy. Gerontology 1997, 43:289-295.
11. Hiatt W.R., Hoag S., Hamman R.F. Effect of diagnostic criteria on the prevalence of peripheral arterial disease. The San Luis Valley Diabetes Study. Circulation 1995, 91:1472-1479.
12. Murabito J.M., Evans J.C., Nieto K., Larson M.G., Levy D., Wilson P.W. Prevalence and clinical correlates of peripheral arterial disease in the Framingham Offspring Study. Am Heart J 2002, 143:961-965.
13. Aronow W.S., Ahn C. Association between plasma homocysteine and peripheral arterial disease in older persons. Coron Artery Dis 1998, 9:49-50.
14. Ridker P.M., Cushman M., Stampfer M.J., et al. Plasma concentration of C-reactive protein and risk of developing peripheral vascular disease. Circulation 1998, 97:425-428.
15. Pradhan A.D., Manson J.E., Rossouw J.E., et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: Prospective analysis from the Women's Health Initiative observational study. JAMA 2002, 288:980-987.
16. Fowkes F.G. Fibrinogen and peripheral arterial disease. Eur Heart J 1995, 16:36-40. discussion 40-41.
17. Fahrleitner A., Dobnig H., Obernosterer A., et al. Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease. J Gen Intern Med 2002, 17:663-669.
18. Malabanan A., Veronikis I.E., Holick M.F. Redefining vitamin D insufficiency. Lancet 1998, 351:805-806.
19. Smith R., Stern G. Muscular weakness in osteomalacia and hyperparathyroidism. J Neurol Sci 1969, 8:511-520.
20. Holick M.F., Chen T.C. Vitamin D deficiency: A worldwide problem with health consequences. Am J Clin Nutr 2008, 87:1080S-1086S.
21. Holick M.F. High prevalence of vitamin D inadequacy and implications for health. Mayo Clin Proc 2006, 81:353-373.
22. Holick M.F. Sunlight, UV-radiation, vitamin D and skin cancer: How much sunlight do we need?. Adv Exp Med Biol 2008, 624:1-15.
23. Holick M.F. Vitamin D deficiency. N Engl J Med 2007, 357:266-281.
24. Li Y.C., Kong J., Wei M., Chen Z.F., Liu S.Q., Cao L.P. 1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system. J Clin Invest 2002, 110:229-238.
25. O'Connell T.D., Berry J.E., Jarvis A.K., et al. 1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy. Am J Physiol 1997, 272:H1751-H1758.
26. Mitsuhashi T., Morris R.C., Ives H.E. 1,25-dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells. J Clin Invest 1991, 87:1889-1895.
27. Watson K.E., Abrolat M.L., Malone L.L., et al. Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation 1997, 96:1755-1760.
28. Targher G., Bertolini L., Padovani R., et al. Serum 25-hydroxyvitamin D3 concentrations and carotid artery intima-media thickness among type 2 diabetic patients. Clin Endocrinol (Oxf) 2006, 65:593-597.
29. Kim D.H., Sabour S., Sagar U.N., et al. Prevalence of hypovitaminosis D in cardiovascular diseases (from the National Health and Nutrition Examination Survey 2001 to 2004). Am J Cardiol 2008, 102:1540-1544.
30. Rajasree S., Rajpal K., Kartha C.C., et al. Serum 25-hydroxyvitamin D3 levels are elevated in South Indian patients with ischemic heart disease. Eur J Epidemiol 2001, 17:567-571.
31. Toda T., Toda Y., Kummerow F.A. Coronary arterial lesions in piglets from sows fed moderate excesses of vitamin D. Tohoku J Exp Med 1985, 145:303-310.
32. Zittermann A., Koerfer R. Protective and toxic effects of vitamin D on vascular calcification: Clinical implications. Mol Aspects Med 2008, 29:423-432.
33. Shroff R., Egerton M., Bridel M., et al. A bimodal association of vitamin D levels and vascular disease in children on dialysis. J Am Soc Nephrol 2008, 19:1239-1246.
34. Suzuki Y., Ichiyama T., Ohsaki A., Hasegawa S., Shiraishi M., Furukawa S. Anti-inflammatory effect of 1alpha,25-dihydroxyvitamin D(3) in human coronary arterial endothelial cells: Implication for the treatment of Kawasaki disease. J Steroid Biochem Mol Biol 2009, 113:134-138.
35. London G.M., Guerin A.P., Verbeke F.H., et al. Mineral metabolism and arterial functions in end-stage renal disease: Potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 2007, 18:613-620.
36. Reis J.P., von Mühlen D., Michos E.D., et al. Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. Atherosclerosis 2009, 207:585-590.
37. Barreto D.V., Barreto F.C., Liabeuf S., et al. Vitamin D affects survival independently of vascular calcification in chronic kidney disease. Clin J Am Soc Nephrol 2009, 4:1128-1135.
38. Forouhi N.G., Luan J., Cooper A., et al. Baseline serum 25-hydroxy vitamin D is predictive of future glycemic status and insulin resistance: The Medical Research Council Ely Prospective Study 1990-2000. Diabetes 2008, 57:2619-2625.
39. Major G.C., Alarie F., Dore J., et al. Supplementation with calcium + vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr 2007, 85:54-59.
40. Rigby W.F., Denome S., Fanger M.W. Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3. Specific inhibition at the level of messenger RNA. J Clin Invest 1987, 79:1659-1664.
41. McCarty M.F. Secondary hyperparathyroidism promotes the acute phase response-a rationale for supplemental vitamin D in prevention of vascular events in the elderly. Med Hypotheses 2005, 64:1022-1026.
42. Reis J.P., Michos E.D., von Muhlen D., Miller E.R. Differences in vitamin D status as a possible contributor to the racial disparity in peripheral arterial disease. Am J Clin Nutr 2008, 88:1469-1477.
43. Briese S., Wiesner S., Will J.C., et al. Arterial and cardiac disease in young adults with childhood-onset end-stage renal disease-Impact of calcium and vitamin D therapy. Nephrol Dial Transplant 2006, 21:1906-1914.
44. Davis W., Rockway S., Kwasny M. Effect of a combined therapeutic approach of intensive lipid management, omega-3 fatty acid supplementation, and increased serum 25 (OH) vitamin D on coronary calcium scores in asymptomatic adults. Am J Ther 2009, 16:326-332.
45. Pilz S., Dobnig H., Fischer J.E., et al. Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke 2008, 39:2611-2613.
46. Scragg R., Jackson R., Holdaway I.M., et al. Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: A community-based study. Int J Epidemiol 1990, 19:559-563.
47. Poole K.E., Loveridge N., Barker P.J., et al. Reduced vitamin D in acute stroke. Stroke 2006, 37:243-245.
48. Holick M.F. The vitamin D epidemic and its health consequences. J Nutr 2005, 135:2739S-2748S.
49. Feldman D., Zhao X.Y., Krishnan A.V. Vitamin D and prostate cancer. Endocrinology 2000, 141:5-9.
50. Hayes C.E., Cantorna M.T., DeLuca H.F. Vitamin D and multiple sclerosis. Proc Soc Exp Biol Med 1997, 216:21-27.
51. Cantorna M.T., Hayes C.E., DeLuca H.F. 1,25-Dihydroxycholecalciferol inhibits the progression of arthritis in murine models of human arthritis. J Nutr 1998, 128:68-72.
52. Mathieu C., Waer M., Laureys J., et al. Prevention of autoimmune diabetes in NOD mice by 1,25 dihydroxyvitamin D3. Diabetologia 1994, 37:552-558.
53. Hypponen E., Laara E., Reunanen A., et al. M. Intake of vitamin D and risk of type 1 diabetes: A birth-cohort study. Lancet 2001, 358:1500-1503.
54. Grant W.B. An estimate of premature cancer mortality in the US due to inadequate doses of solar ultraviolet-B radiation. Cancer 2002, 94:1867-1875.
55. Bischoff H.A., Stahelin H.B., Dick W., et al. Effects of vitamin D and calcium supplementation on falls: A randomized controlled trial. J Bone Miner Res 2003, 18:343-351.
56. Peiris A.N., Bailey B.A., Manning T. The relationship of vitamin D deficiency to health care costs in veterans. Mil Med 2008, 173:1214-1218.
57. Wallis D.E., Penckofer S., Sizemore G.W. The " sunshine deficit" and cardiovascular disease. Circulation 2008, 118:1476-1485.